CoChat

Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development

The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.

Abstract

Blocking the interactions between bromodomain and extraterminal (BET) proteins and acetylated lysines of histones by small molecules has important implications for the treatment of cancers and other diseases. Many pan-BET inhibitors have shown satisfactory results in clinical trials, but their potential for poor tolerability and toxicity persist. However, recently reported studies illustrate that some BET bromodomain (BET-BD1 or BET-BD2)-selective inhibitors have advantage over pan-inhibitors, including reduced toxicity concerns. Furthermore, some selective BET inhibitors have similar or even better therapeutic efficacy in inflammatory diseases or cancers. Therefore, the development of selective BET inhibitors has become a hot spot for medicinal chemists. Here, we summarize the known selective BET-BD1 and BET-BD2 inhibitors and review the methods for enhancing the selectivity and potency of these inhibitors based on their different modes of interactions with BET-BD1 or BET-BD2. Finally, we discuss prospective strategies that selectively target the bromodomains of BET proteins.

Overview

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.1c01835

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 117 references

Cited by

See all 62

Metadata

Authors
Chen, J., Tang, P., Wang, Y., Wang, J., Yang, C., Li, Y., Yang, G., Wu, F., Zhang, J., & Ouyang, L.
Affiliations
  • Sichuan University (CN)
  • University of Tennessee Health Science Center (US)
Corresponding author
  • Zhang, Jifa
  • Ouyang, Liang
Venue
Journal of Medicinal Chemistry
Published
2022-03-24
Volume
65
Issue
7
Pages
5184-5211
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W4220998638
Cited by
62
References
117
Citations by year
2026: 11 · 2025: 16 · 2024: 18 · 2023: 13 · 2022: 4
FWCI
4.16
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Science and Technology of the People's Republic of China (2018ZX09201018-021)
  • China Postdoctoral Science Foundation (2020M673268)
  • Department of Science and Technology of Sichuan Province (2019YFS0003)
  • National Natural Science Foundation of China (81874290, 81903502, 81922064, 82073318)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
Keywords
BET proteins, bromodomain inhibitors, selective inhibitors, histone acetylation, drug selectivity, drug toxicity, cancer therapy, inflammatory diseases, small molecule inhibitors
MeSH terms
Protein Domains, Histones, Humans, Neoplasms, Prospective Studies, Transcription Factors, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development. https://app.cochat.ai/papers/10.1021/acs.jmedchem.1c01835
The paper
Chen, J., Tang, P., Wang, Y., Wang, J., Yang, C., Li, Y., Yang, G., Wu, F., Zhang, J., & Ouyang, L. (2022). Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.1c01835

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.